Rare diseases
Investigational molecules
Locations
Back to Sweden252 clinical trials in Stockholm, Sweden across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SwedenKliniska-Provningar.se(opens in a new tab)Study on the Effectiveness and Safety of Deucravacitinib for Adults with Active Sjogren's Syndrome
SwedenStudy on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
SwedenStudy on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
SwedenStudy of RBD5044 in Adults with Mixed Dyslipidemia to Evaluate its Safety and Effectiveness
SwedenA Study of Baricitinib to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes
SwedenLong‑Term Safety and Efficacy Study of Danicamtiv in Adults with Symptomatic Genetic and Familial Dilated Cardiomyopathy
SwedenStudy of AZD6234 (lenbelintide) Added to Incretin Therapy in Adults with Obesity or Overweight and a Weight‑Related Comorbidity, With or Without Type 2 Diabetes
SwedenEffect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)
SwedenSafety and Pharmacodynamics of RBD4059 and Apixaban in Patients with Non‑Valvular Atrial Fibrillation: A Randomized Active‑Controlled Study
SwedenCabozantinib Maintenance Therapy vs Best Supportive Care in Osteosarcoma Patients in Complete Remission or with Residual Disease after First‑Line Chemotherapy
SwedenEfficacy of intravenous prasinezumab versus placebo in Parkinson's disease patients with severe GBA mutation: a 104‑week randomized double‑blind study
SwedenVenetoclax added to fludarabine, cytarabine and gemtuzumab ozogamicin (drug combination) in children with relapsed acute myeloid leukemia
SwedenThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on metastatic prostate cancer and advanced breast cancer treatments, evaluating new therapeutic approaches and drug combinations.
Innovative research comparing various treatment protocols and investigating survival outcomes.
Studies evaluating vaccines and treatments for respiratory syncytial virus, herpes zoster, and HPV infections.
Focus on prevention and immune response in various age groups.
Research on heart failure prevention and hypertrophic cardiomyopathy, testing new therapeutic combinations.
Emphasis on improving patient outcomes and testing novel drug combinations.
Trials investigating treatments for Parkinson's disease and multiple sclerosis, focusing on disease progression and symptom management.
Studies evaluating both novel and existing therapeutic approaches.
Research on obesity and type 2 diabetes treatments, evaluating new medications for weight management.
Focus on lifestyle interventions combined with pharmaceutical approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
